1 Min Read
Nov 8 (Reuters) - Vtv Therapeutics Inc:
* Vtv Therapeutics Inc - vtv Therapeutics initiates phase 1B/2 study evaluating TTP399 for treatment of type 1 diabetes Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.